ADAR1 Capital Management GP, LLC (CIK 1940267) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-15). Recent activity: Sell KROS (4.4M shares), Sell KROS (254,669 shares), Sell KROS (743,358 shares), Sell KROS (100 shares), Sell KROS (1,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 4.4M | $77.9M |
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 254,669 | $4.5M |
| 2025-10-15 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 743,358 | $13.2M |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 100 | $6,000 |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 1,400 | $98,000 |
| 2025-06-24 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 200 | $14,000 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Buy | 18,560 | $174,464 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Buy | 16,365 | $153,831 |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Buy | 325,000 | $3.2M |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Buy | 500,000 | $5.2M |
| 2025-04-11 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Buy | 74,333 | $767,860 |
Source: SEC Form 4 filings · as of 2025-10-15